Scheen has received consultancy fees or honoraria from the following companies: AstraZeneca, Boehringer Ingelheim, BristolMyers Squibb, Eli Lilly, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, NovoNordisk, SanofiAventis, and Servier
According to the American Society for Dermatologic Surgery, the FDA proposed an OTC ban way back in 2006, recommending more studies by the National Toxicology Program (NTP) due to as-yet-unproven concerns that it may cause cancer, as well as concerns over ochronosisskin darkening (in other words, the opposite of what most hydroquinone users are going for)
Low-carb diets, intermittent fasting, and plant-based eating plans have gained popularity in recent years, offering potential benefits for weight loss and overall health
Learn more: To view or add a comment, sign in 102,033 followers